#Japan #Kagoshima #AMI Corporation #Cardio-EGG #Cloud超診

AMI Corporation Recognized for Healthcare Innovation

AMI Corporation, headquartered in Kagoshima City and with offices in Minamata City, has recently been honored with the Startup Encouragement Award at the 8th Japan Medical Research Development Award. This notable achievement celebrates significant contributions to the advancement of medical research and development, aiming to enhance public interest and understanding in the healthcare field. Since its inception in 2017, the award has recognized various innovations in Japanese medical research, and AMI is proud to be the first recipient from Kagoshima Prefecture.

The Award Highlights

The company’s groundbreaking work focuses on the digitization of "auscultation" through its developed medical device, the "Cardio-EGG." This innovative technology aims to facilitate non-invasive, rapid, and cost-effective screening for cardiovascular diseases. By combining Cardio-EGG with its telehealth support system, "Cloud超診," AMI Corporation has made it possible to conduct swift evaluations of cardiovascular conditions remotely.

The Cardio-EGG device received regulatory approval in 2022, marking a significant step in its journey toward widespread use. Furthermore, the development of the general-purpose acoustic measuring program, known as the "Digital Biomarker DNP-HF," is expected to gain regulatory approval in 2025, positioning AMI for further advancements in software as a medical device (SaMD).

About the Japan Medical Research Development Award

The Japan Medical Research Development Award is bestowed by the Prime Minister's Office of Japan. It recognizes remarkable contributions to the field of medical research and encourages further advancements in this vital sector. The program has been pivotal in promoting research endeavors and amplifying incentives for researchers, thereby broadening public engagement in health-related topics.

For more information on the awards, you can refer to the official pamphlet.

About AMI Corporation

Founded in November 2015, AMI Corporation is a research-driven startup committed to advancing AI healthcare devices and the implementation of telemedicine services. Our mission is to create a society in which optimal healthcare can be accessed anytime, anywhere, and by anyone. This commitment encompasses the social implementation of our advanced stethoscope technologies, which comprise hardware (Cardio-EGG), software (Cloud超診), AI technology, and knowledge.

We invite you to explore our promotional video to learn more about our revolutionary approach to healthcare: Watch Here.

Company Overview

• - Company Name: AMI Corporation
• - CEO: Shinpei Ogawa
• - Establishment: November 2015
• - Website: AMI Corporation
• - Headquarters Address: 2-13 Higashisenmachi, Kagoshima City, Room 302
• - Main Office Address: 5-98 Hamamatsu Town, Minamata City
• - Business Scope: Development of medical devices and provision of telemedicine services.

This announcement is intended for stakeholders, including media representatives and investors. It is not intended for providing medical information or attracting customers.